Future, nature and culture: France eyes on Silicon Beach of India
: The recent visit of Consulate General of France in Bengaluru to Mangaluru generated significant interest among officials, who are now actively seeking French business establishments in the coastal region.
A
French delegation
led by Pierre Beaudoin, Economic Attaché, and Marc Lamy, Consul General of France at the French Consulate General in Bengaluru, toured various IT facilities and engaged with local enterprises, learning about Mangaluru's expanding technological landscape.Rohit Bhat, founding-president of TiE Mangaluru, said the Consul General was impressed by the fact that the region has 'future, nature and culture'. The future to grow, a blend of nature with greenery, mountains, and beaches, and diverse culture.
Operation Sindoor
PM Modi meets NSA, chiefs of armed forces amid spike in tensions with Pak
India's air defence systems shoot down Pak drones in J&K, Punjab & Rajasthan
Several airports in India to be closed till May 15 - check list
"This is the biggest takeaway the delegation had from the recent visit," he said, adding that the region has currently one French-based company.Mukesh S from
Silicon Beach of India
, told TOI that Bengaluru has several French companies, including leading ones. The delegation was impressed by the availability of the abundant talent pool, rich cultural diversity, food, vast coastline with watersports such as surfing, and quality of life. During their two-day visit to the coast, the delegation visited Mantra Surf Club, which showcased the city's emerging
eco-tourism
potential.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
AI guru Andrew Ng recommends: Read These 5 Books And Turn Your Life Around in 2025
Blinkist: Andrew Ng's Reading List
Undo
They were introduced to the Silicon Beach Programme and visited innovative companies like UniCourt (LegalTech) and Novigo Solutions (automation and cybersecurity). The final stop was a tour of Pilikula Nisargadhama, including the artisan village and the king cobra breeding centre, providing a glimpse into the region's ecological richness. They also held engagements by visiting Vertex Workspace and LCode Technologies, interacting with local companies and gaining insights into Mangaluru's growing tech ecosystem.
Later, they visited Sahyadri College of Engineering and Management and Shine Foundation, focusing on the collaboration potential between academia and innovation."We have been informed by the delegation that they were positive about the region, and would want to understand more about the ecosystem. Another delegation would visit the region soon," Mukesh said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
6 minutes ago
- Time of India
Qualcomm localising module production in India, supporting partners' manufacturing plans
US-based chip major Qualcomm is localising automotive module production in India and is supporting its top-tier ecosystem partners in their plan to move manufacturing into the country, a senior company official has said. Qualcomm Technologies, group general manager for automotive, industrial and embedded IoT, Nakul Duggal, told PTI that the company is investing heavily in India to support local automotive companies. "We build a lot of modules. Those modules are typically built in Taiwan, or China, or Korea, but we are now actively working in India to localise this. We, of course, partner with our Tier 1 ecosystem, such that as they move their manufacturing to India, we have been supporting them," he said. Duggal said that Qualcomm is a fabless company, which means it designs the chips but doesn't manufacture them. "For us, it's really about being able to create opportunities in our supply chain to be able to direct that (manufacture)," he said. Qualcomm has approximately 22,000 employees, or 60 per cent of its workforce, in India. Duggal said that the company has a local team to support domestic car manufacturers. Qualcomm has been bullish on chipsets for automobiles , especially electric vehicles . The company has partnered with all the major car OEMs (original equipment manufacturers), including Tata Motors, Mahindra, Maruti Suzuki and Hyundai, to provide them with chipsets for modernising cars. It has the Snapdragon Elite chipset platform for telematics, infotainment and driver assistance, including ADAS (Advanced Driver Assistance Systems). Duggal said that in 2026, there will probably be a dozen vehicles that will deploy its Snapdragon Cockpit Elite and Snapdragon Ride Elite SoC (System on Chip), which were announced in October 2024 and delivered to customers in early 2025. He said that India has a substantial domestic footprint encompassing both domestic and global automakers that manufacture locally. "There is a huge need for building products that cater to the needs of the Indian region. Rather than bringing in a product that is built for a global customer, build a product for a local customer. That necessitates for an OEM the need to have engineering capability, creative capability, to actually think about the needs of the local region, and we are starting to see that happen," he said. Duggal said building an automotive product for the local market will generate a competitive advantage, and China has benefited from this trend. The automotive segment of the company accounts for around 10 per cent of its global revenue, which is around USD 3.6 billion to USD 3.8 billion. The company has set a target to double the total revenue from the automotive business to about USD 8 billion by 2029.
&w=3840&q=100)
Business Standard
6 minutes ago
- Business Standard
Alkem Labs Q1 profit rises 22% to ₹664 cr on India, overseas sales growth
Alkem Laboratories on Tuesday reported a 22 per cent year-on-year (Y-o-Y) rise in its consolidated net profit for the June quarter (Q1FY26) to ₹664.3 crore, up from ₹545.2 crore in the same period last year. Revenue from operations increased 11.2 per cent Y-o-Y to ₹3,371 crore in Q1FY26 from ₹3,031 crore in Q1FY25. The company attributed this growth to strong sales in both India and international markets. Commenting on the performance, Vikas Gupta, Chief Executive Officer of Alkem, said Q1FY26 marked a strong start to the year, with healthy growth across both domestic and overseas markets. India sales grew 12 per cent Y-o-Y to ₹2,265 crore in the June quarter, while international sales rose 8.9 per cent to ₹1,054 crore, contributing 31.7 per cent to overall revenue. In the international business, the United States market recorded sales of ₹698 crore, up 8.8 per cent from ₹641.6 crore a year earlier, contributing 21 per cent to total sales. Sales from other international markets — including Latin America, Australia, and Europe — rose 9.1 per cent to ₹355.6 crore, contributing 10.7 per cent to revenue. Gupta said the company is strategically accelerating its focus on the non-US business segment by strengthening its presence in high-potential markets and capturing new opportunities aligned with Alkem's long-term growth ambitions. Alkem also announced it will incorporate a Saudi Arabia-based subsidiary, holding a 51 per cent stake. 'The subsidiary is proposed to be incorporated as a limited liability company and will be involved in the manufacture, import, marketing, and distribution of pharmaceutical and/or nutraceutical products within the Kingdom of Saudi Arabia,' the company said in a filing to the exchanges. On Tuesday, Alkem Laboratories' share price rose 6.7 per cent to close at ₹5,167 on the Bombay Stock Exchange (BSE).
&w=3840&q=100)
Business Standard
6 minutes ago
- Business Standard
Zydus Lifesciences Q1 PAT up 5.9% on strong India, int'l formulations biz
Ahmedabad-based Zydus Lifesciences on Tuesday reported a 5.9 per cent year-on-year (Y-o-Y) increase in consolidated net profit for the June quarter (Q1FY26) to ₹1,466 crore, up from ₹1,419 crore in the same quarter last year. Revenue from operations rose 3.3 per cent Y-o-Y to ₹6,573 crore in Q1FY26 from ₹6,207 crore in Q1FY25. The growth was driven by strong performances in the company's domestic and international formulations segments, even as its consumer wellness and US businesses saw muted growth. In Q1FY26, the India formulations business grew 5.8 per cent Y-o-Y to ₹2,374 crore, with the company stating that its branded formulations segment outperformed the market in both chronic and acute categories. The international markets formulations business posted a 36.8 per cent Y-o-Y increase to ₹726.5 crore, while the active pharmaceutical ingredients (API) segment rose 11.3 per cent to ₹157.5 crore. 'All-round growth across key geographies was driven by strong demand and focused execution,' Zydus said in a filing to the exchanges. The US market, which contributes 49 per cent of consolidated revenue, saw only a 2.9 per cent Y-o-Y increase to ₹3,181 crore, despite the launch of three new products during the quarter. The consumer wellness business, contributing 13 per cent to consolidated revenue, grew 2 per cent Y-o-Y to ₹854.9 crore, with performance impacted by seasonal brands. However, the company said its core wellness brands posted strong double-digit growth, reflecting the underlying strength of its portfolio and balanced business model. Commenting on the results, Sharvil Patel, Managing Director of Zydus Lifesciences, said the Q1 performance reflected disciplined execution, with most key businesses meeting expectations. 'We remain firmly on track to achieve our FY26 aspirations and are excited about the upcoming developments on the innovation front, which we believe will open up new avenues for sustainable growth,' Patel added. On Tuesday, Zydus Lifesciences shares closed flat with a 0.05 per cent rise at ₹956 apiece on the Bombay Stock Exchange (BSE).
